The Next Generation of Mouse Model Preparation Platform
VeloGene Articles & Resource
TurboMice™ - Preclinical Frontier by VelogoGene
In 2024, major pharmaceutical corporations heavily invested in the TIGIT (T cell immunoreceptor with...
On November 7–10, 2025, the American Heart Association (AHA) Scientific Sessions was held in New Orleans,...
On June 9, 2025, Xinya Gene announced that GEN6050X, its proprietary in vivo base-editing therapeutic...
IP Assurance
At VeloGene, we operate on a strict fee-for-service model. All intellectual property (IP) and materials created for your project are 100% yours. We take every measure to safeguard your IP, ensuring no vectors, ES cells, or mouse lines are retained or resold to third parties. This way, you can focus on your research with complete peace of mind.